Daniel Carcillo On Psychedelics For TBI, Wesana Partnering With MAPS & Mike Tyson Collaboration

During our time at Wonderland Miami, $PSYC CEO, David Flores, had the pleasure of sitting down with Wesana Health CEO, Daniel Carcillo, to talk about the significance of the conference and what it means to the arrival of the psychedelics industry. They also spent some time discussing Wesana’s collaboration with MAPS and the value that Mike Tyson is helping to create as a strategic partner to Wesana.
In this episode, you’ll be able to learn more about:
– Wesana’s collaboration on MAPS
– Maps accelerating TBI much faster
– Mike Tyson partnership significance
– Removing psychedelics’ stigma and describing them as medicines,
– The most important psychedelic highlights of 2021

#DanielCarcillo #Psychedelics #Wesana

source

Psychedelic Spotlight

Minimizing Harm and Ensuring Safe Nonclinical Psychedelic Use – Fireside Project

September 7, 2023June 2, 2024 Listen, Podcasts

In this captivating episode, David engages in a thought-provoking conversation with none other than Joshua White, the visionary CEO behind the Fireside Project.

UFC Explores Psychedelic Therapy for Brain-Injured Fighters

March 22, 2021June 2, 2024 Listen, Psychedelic Spotlight Videos

The UFC (Ultimate Fighting Championship) is working with industry leaders to better understand brain trauma-related problems the combat sport causes athletes. As part of that effort, the organization is taking a long, hard look at psychedelic therapies as possible treatments.

The Revolution in Mental Health Care: Psychedelics | PSILERA

December 7, 2021June 2, 2024 Listen, Psychedelic Spotlight Videos

In today’s episode, we speak with the leaders of Psilera…

Psychedelic Spotlight Interview with Daniel Carcillo

September 15, 2021June 2, 2024 Listen, Psychedelic Spotlight Videos

In this episode of the Psychedelic Spotlight podcast, we catch…

My NEW Top 5 Psychedelic Stocks for 2021 || MindMed, NUMI, Atai and More

April 30, 2021June 2, 2024 Listen, Videos

Here are our Top 5 Best Psychedelic Stock Picks for 2021. For those who have watched our top 5 shroom stocks for 2020, you might notice that some stocks have stayed and others have been replaced because they have proven to be worthy of The Psychedelic Investor’s list by filling in the top 3 factors that we look at before investing in the psychedelic medicines industry, such as:
Clinical Trial Progress
Molecules & Compounds Pipeline
The Company’s war chest to sustain growth as a biotech company in a new industry

But why invest in psychedelic stocks?
Ever since last year, celebrity investors such as Kevin O’Leary and Peter Thiel decided to invest in the psychedelic/ shroom stocks industry, the industry grew from 2 or 3 companies to approximately 30 in 2021. This is probably one of the main reasons why we call this phenomenon the SHROOM BOOM!
But why do such investors seem to believe so much in the potential explosive growth of psychedelic stocks?
1. Psychedelics have been shown in many recent clinical trials to help a variety of mental health issues, from addiction, to depression to PTSD and more.
2.These psychedelic companies are attempting to disrupt the 100 billion annual industry for mental health pharmaceuticals.
3.These psychedelic compounds have the potential to help millions world wide, this also presents an amazing opportunity for early investors.
4.Smart investors might realize that rather than going all in on one company in the field, it is probably best to diversify your risk and create a Psychedelic Medicines portfolio.

So our top 5 Shroom Stock Pics for 2021 are:
5. Cybin ( CYBN on NEO & CLXPF on the OTC)
4. Numinus Wellness (LKYSF on the OTC & NUMI on the TSX)
3. Compass Pathways (CMPS on Nasdaq)
2. Atai Life Sciences – Soon to IPO on the Nasdaq
1 Mind Medicine or MindMed (MMED on NEO MNMD on Nasdaq & MMQ on FRA)
Link to Cybin (CYBN) : https://www.cybin.com/
Link to Numinus (NUMI) : https://numinus.ca/
Link to Compass Pathways (CMPS) : https://ir.compasspathways.com/static-files/fe6cc477-a2ee-4b4a-bd46-8f8df0b62f30
Link To Atai life Sciences: https://www.atai.life/
Linke To MindMed (MMED / MNMD / MMQ) https://mindmed.co/

Timestamps:
0:00 – Intro
1:58 – Ranking criteria
3:42 – Cybin (CYBN) ( CLXPF)
6:24 – Numinus Wellness ( NUMI)
10:04 – Compass Pathways (CMPS)
13:52 – Atai Life Sciences
18:50 – MindMed ( MMED / MNMD/ MMQ )

Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news!
Follow us on social media! 🙌

Instagram: @psychedelicinvestor
Email: thepsychedelicinvestor@gmail.com
Facebook: @thepsychedelicinvestor
Music: www.bensound.com
https://benzinga.grsm.io/jameshallifax1834
https://benzinga.grsm.io/thepsychedelicinvestor

Clinical trials :

DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.

All of the information in this video is public information that James (The Psychedelic Investor) believes to be reliable but it is not guaranteed to be 100% accurate and as such should not be used as advice. Any opinions or thoughts from James (The Psychedelic Investor) are subject to change.

#MindMed #PsychedelicStocks #CMPSStock

My Neuroplastic Adventure with Victor Mifsud

February 3, 2023June 2, 2024 Listen, Podcasts

In this episode, Dennis Walker speaks with Victor Mifsud about how a few MDMA experiences helped him have a temporary remission of his retinitis pigmentosa, a disease which has caused him to be legally blind.